Patents by Inventor Florian Andreas Rampf

Florian Andreas Rampf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Picolinic acid derivatives and their use as intermediates
    Patent number: 10633341
    Abstract: The present invention relates to new picolinic acid derivatives of formula (I) and their use as intermediates in the process of making pyridine derivatives, including (S)-3-amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide that are useful for the treatment of respiratory disorders.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: April 28, 2020
    Inventors: Thomas Heinz, Benjamin Martin, Florian Andreas Rampf, Werner Zaugg
  • NEW PICOLINIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIATES
    Publication number: 20190345107
    Abstract: The present invention relates to new picolinic acid derivatives of formula (I) and their use as intermediates in the process of making pyridine derivatives, including (S)-3-amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide that are useful for the treatment of respiratory disorders.
    Type: Application
    Filed: December 18, 2017
    Publication date: November 14, 2019
    Inventors: Thomas HEINZ, Benjamin MARTIN, Florian Andreas RAMPF, Werner ZAUGG
  • HIGHLY CRYSTALLINE VALSARTAN
    Publication number: 20130137737
    Abstract: The present invention describes a highly crystalline form of valsartan, pharmaceutical compositions thereof and process for the preparation thereof.
    Type: Application
    Filed: August 1, 2011
    Publication date: May 30, 2013
    Applicant: NOVARTIS AG
    Inventors: Jens Burgbacher, Björn Thomas Hahn, Florian Andreas Rampf, Ricardo Schneeberger
  • PROCESS FOR THE MANUFACTURE OF ORGANIC COMPOUNDS
    Publication number: 20120238761
    Abstract: The present invention relates to processes for the manufacture of an angiotensin receptor blocker (ARB; also called angiotension II receptor antagonist or AT1 receptor antagonist) and salts thereof, to novel intermediates and process steps.
    Type: Application
    Filed: October 25, 2010
    Publication date: September 20, 2012
    Inventors: Gottfried Sedelmeier, Florian Andreas Rampf, Dominique Grimler